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.2012.03.0Abstract Uremia means excess nitrogenous waste products in the blood & their toxic effects. An
acute acetaminophen (paracetamol, N-acetyl p-aminophenol; APAP) overdose may result into
potentially fatal hepatic and renal necrosis in humans and experimental animals. The aims of this
present study were to investigate the protective effect of alpha-lipoic acid (ALA) on oxidative stress
& uremia on male albino rats induced by acetaminophen. The study was performed by 24 albino
male Wister strain rats which were randomly divided into four groups: Group I, control – receives
normal food and water, Groups II, III & IV receive acetaminophen interperitoneally at the dose of
500 mg/kg/day for 10 days, from 11th day Groups III & IV were treated with ALA at the dose of
5 mg & 10 mg/100 g/day for 15 days, respectively. After 25 days of treatment, it was observed that
there was a signiﬁcant increase in plasma urea, creatinine, sodium and malondialdehyde (MDA)
levels (p< 0.05) but a signiﬁcant decrease in super oxide dismutase (SOD) & catalase activity &
potassium level in uremic group is compared with control group & there was a signiﬁcant increase
in SOD & catalase (p< 0.05) & a signiﬁcant decrease in serum urea, creatinine & Na and MDA
(p< 0.05) in Group III & Group IV is compared with Group II & signiﬁcant changes were
observed in high ALA dose group. In conclusion it was observed that the ALA has nephroprotec-
tive activities by biochemical observations against acetaminophen induced uremic rats.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.9434229882,+91 9932241708.
o.co.in (D.K. Nandi).
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031. Introduction
At present kidney diseases appear to be a major problem across
the globe. As per global and regional overview, 17,83,000
patients are suffering from End Stage Renal Disease of which
dialysis has been given to 13,71,000 patients and kidney has
been transplanted in 4,12,000 patients suffering from renal
failure, live under particularly pro-oxidative conditions causing
uremia (Moeller et al., 2004; Toborek et al., 1992). Uremia is a
potentially fatal condition that demands immediate treatmentier B.V. All rights reserved.
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transplant and dialysis (Tsuchiya and Sato, 1990), which are
very expensive, time-consuming, complicated techniques and
are not free from side effects. There is great urgency for a
nonconventional, affordable therapy for patients who cannot
afford expensive dialysis or kidney transplant to keep them
alive. Many studies have been showed that herbal therapy
may be the sort out of this global problem of uremia (Das
et al., 2010a,b). Acetaminophen is a commonly used
antipyretic agent which, in high doses, causes renal tubular
damage and uraemia. An acute acetaminophen (paracetamol,
N-acetyl p-aminophenol; APAP) overdose may result into
potentially fatal hepatic and renal necrosis in humans and
experimental animals (Jones and Vale, 1993). Acetaminophen
induced oxidative stress results in lipoperoxidation, protein
thiol oxidation, mitochondrial endoplasmic reticulum injury,
altered homeotaxis and irreversible DNA damage character-
ized by protein adduct formation (Sies, 1993). Previous
research work suggests that LA ameliorate the lipid peroxida-
tion and the loss of cellular anti-oxidants, thereby protecting
the CQ-induced oxidative damage in kidney (Murugavel and
Pari, 2004). Recent evidence established that alpha-lipoic acid
co-treatment signiﬁcantly inhibited the levels of lipid hydroper-
oxide, protein carbonyl contents & stimulated anti-oxidants
enzyme activities like SOD, GPx and GST & CAT. The
observed increase in total anti-oxidants & anti-oxidant enzyme
levels with alpha-lipoic acid treatment to lead ingesting rats
could be due the anti-oxidant effects of alpha-lipoic acid
(Caylak et al., 2008). The aim of this study was to search out
the possible effect of alpha-lipoic acid on acetaminophen
induced uremic rats.
2. Materials & methods
2.1. Selection of animals and care
The study was conducted on 24 healthy, adult, male albino rats
of Wister strain (Supplied from Ghosh animal, animal foods
and animal cages Supplier, Kolkata 54) having a body weight
of 100 ± 15 g. They were acclimatized to laboratory condition
for 2 weeks prior to experimentation. Animals were housed
three rats/cage in a temperature-controlled room (22 ± 2 C)
with 12–12 h dark–light cycles (8.00–20.00 h light, 20.00–
8.00 h dark) at a humidity of 50 ± 10%. They were provided
with standard food and water ad libitum. Animal care was pro-
vided according to the Guiding Principle for the Care and Use
of Animals (Olert et al., 1993).
2.2. Grouping of animals & experimental procedure
The rats were divided into four equal groups as follows:
Group I or control – Six animals were subjected to control
group. They were housed at room temperature (25 ± 3 C) &
feed normal diet & water ad libitum.
Group II or acetaminophen induced uremic – Six animals
were randomly placed in cage with normal diet & injected with
acetaminophen at the conc. of 500 mg with de-ionized water
5 mL/kg of body weight/day for 10 days to achieve uremia.
Group III or acetaminophen with treatment by ALA – Six
animals were randomly placed in cage with normal diet & trea-
ted similarly as uremic group & co-administered with ALA at
the dose of 50 mg/0.5 mL de-ionized water/kg body weight/rat,respectively, by forceful feeding for 15 days at daily 10.00
A.M. before giving the food.
Group IV or acetaminophen with treatment by ALA – Six
animals were randomly placed in cage treated similarly as ure-
mic group & co-administered with ALA at the dose of 100 mg
/0.5 mL de-ionized water/kg body weight/rat, respectively, by
forceful feeding for 15 days at daily 10.00 A.M. before giving
the food.
2.3. Animals sacriﬁced & plasma & organ collection
This experimental design was continued for 25 days. After
25 days, the animals were sacriﬁced & blood was collected
from the aorta after which the kidneys were collected for dif-
ferent biochemical analysis.
2.4. Methods of measuring the concerned parameters
2.4.1. Blood uremia proﬁle
2.4.1.1. Biochemical estimation of blood urea (Burtis and
Ashwood, 1999). The collected blood was centrifuged and plas-
ma fraction was separated. Urea level of plasma was measured
by commercially available standard Blood Urea Kit (Merck,
Japan) by Semiautoanalyzer (Merck, Japan) by standard pro-
tocol for photometric determination of urea according to the
Urease GLDH method (kinetic UV test).
2.4.1.2. Biochemical estimation of blood creatinine (Sabbagh
et al., 1988). The collected blood was centrifuged and plasma
fraction was separated. The plasma creatinine level was mea-
sured by commercially available standard Blood Urea Kit
(Merck, Japan) by Semiautoanalyzer (Merck, Japan) by stan-
dard protocol for phtotometric determination of creatinine
based on Jaffe kinetic method without de-proteinization.
2.4.2. Anti-oxidant enzymes
2.4.2.1. Biochemical assay of catalase activity (Beers and Sizer,
1952). Catalase activity (CAT) was measured biochemically.
For the evaluation of CAT in plasma, the collected blood
was centrifuged and the plasma fraction was separated. The
kidneys were homogenized separately in 0.05 M Tris hydro-
chloric acid (HCl) buffer solution (pH – 7.0) at a tissue concen-
tration of 50 mg/mL. These homogenates were centrifuged
separately at 10,000g at 4 C for 10 min. Following this,
0.5 mL of hydrogen peroxide (H2O2) and 2.5 mL of distilled
water were mixed and reading of absorbance was noted using
a spectrophotometric cuvette at 240 nm. Forty microliters of
tissue supernatant and plasma were added separately and six
subsequent readings were noted at 30 s intervals.
2.4.2.2. Biochemical assay of superoxide dismutase (SOD)
(Marklund and Marklund, 1974). The kidneys were homoge-
nized in ice-cold 100 mM Tris–cocodylate buffer to give a tis-
sue concentration of 50 mg/mL and centrifuged at 10,000g for
20 min at 4 C. The SOD activity of the supernatant was esti-
mated by measuring the percentage of inhibition of the pyra-
gallol autooxidation by SOD. The buffer was 50 mM Tris
(pH – 8.2) containing 50 mM cocodylic acid (pH – 8.2),
1 mM ethylene diamine tetra acetic acid (EDTA) and 10 mM
hydrochloric acid (HCl). In a spectrophotometric cuvette,
2 mL of buffer, 100 lL of 2 mM pyragallol and 10 lL of
Table 1 Anti-uremic & anti-oxidative effect of alpha-lipoic acid at two different doses (50 & 100 mg/kg of body weight) on body
growth on acetaminophen induced uremic male albino rats. Data are expressed as mean ± S.E. (n= 8). ANOVA followed by multiple
two-tail t-test and data with different superscripts (a, b, c, d) in a speciﬁc vertical column differ from each other signiﬁcantly (p< 0.05).
Group Initial body weight (g) Final body weight (g) Increases or decreases in body weight (g %) Kidney somatic index (g)
I 99.16 ± 3.83 121 ± 5.16a 21.63 0.70 ± 0.05a
II 98.33 ± 4.34 100.17 ± 3.56b 1.75 0.62 ± 0.01a
III 97.5 ± 6.77 112.5 ± 7.4722c 14.74 0.77 ± 0.02ab
IV 100 ± 4.08 100.83 ± 3.837b 1.126 0.92 ± 0.03c
Group I – control, Group II – acetaminophen induced uremia, Groups III and IV – acetaminophen + co-administration of ALA at the dose 50
& 100 mg/100 g of body wt., respectively.
Table 3 Anti-uremic & anti-oxidative effect of alpha-lipoic
acid at two different doses (50 & 10 mg/kg of body weight) on
plasma & kidney MDA on acetaminophen induced uremic
male albino rats. Data are expressed as mean ± S.E. (n= 8).
ANOVA followed by multiple two-tail t-test and data with
different superscripts (a, b, c, d) in a speciﬁc vertical column
differ from each other signiﬁcantly (p< 0.05).
Group Plasma Kidney
MDA (n mol/dL of plasma) MDA (n mol/mg of tissue)
I 25.80 ± 1.34a 40.27 ± 1.69a
II 45.78 ± 1.58b 98.82 ± 3.79b
III 38.14 ± 1.14c 74.30 ± 2.68c
IV 28.15 ± 1.85a 61.75 ± 2.10d
Group I – control, Group II – acetaminophen induced uremia,
Groups III & IV – acetaminophen + co-administration of ALA at
the dose 50 & 100 mg/kg body wt., respectively.
Table 2 Anti-uremic & anti-oxidative effect of alpha-lipoic acid at two different doses (50 & 100 mg/kg of body weight) on plasma
and kidney SOD & catalase on acetaminophen induced uremic male albino rats. Data are expressed as mean ± S.E. (n= 8). ANOVA
followed by multiple two-tail t-test and data with different superscripts (a, b, c, d) in a speciﬁc vertical column differ from each other
signiﬁcantly (p< 0.05).
Groups Plasma Kidney
Catalase (m mol of H2O2
consumption/dL of
plasma/min)
SOD (m mol of H2O2
consumption/dL of
plasma/min)
Catalase (m mol of H2O2
consumption/mg of
tissue/min)
SOD (m mol of H2O2
consumption/mg of
tissue/min)
I 0.711 ± 0.04a 0.65 ± 0.04a 0.57 ± 0.05a 0.89±0.14a
II 0.343 ± 0.02b 0.09 ± 0.01b 0.22 ± 0.03b 0.20±0.13b
III 1.44 ± 0.04c 0.44 ± 0.12c 0.42 ± 0.02c 0.55±0.13c
IV 2.69 ± 0.18d 0.60 ± 0.09a 0.79 ± 0.09d 0.62±0.14a
Group I – control, Group II – acetaminophen induced uremia, Groups III & IV – acetaminophen + co-administration of ALA at the dose 50 &
100 mg/kg of body wt., respectively.
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spectrophotometer at 420 nm for 3 min. One unit of SOD
was deﬁned as the enzyme activity that inhibited the autooxi-
dation of pyragallol by 50%.
2.4.3. Oxidative stress marker
2.4.3.1. Biochemical estimation of MDA (Ohkawa et al., 1979).
The kidneys were homogenized separately at a tissue concen-
tration of 50 mg/mL in 0.1 M of ice-cold phosphate buffer
(pH = 7.4) and the homogenates and blood samples were sep-
arately centrifuged at 10,000 g at 4 C for 5 min. Supernatant
and plasma were used for the estimation of MDA and CD.For the measurement of MDA, 0.5 mL homogenate and plas-
ma were mixed separately with 0.5 mL normal saline and 2 mL
of TBA-TCA mixture (0.392 g of TBA in 75 mL of 0.25 N HCl
with 15 g of TCA, with the ﬁnal volume of the mixture being
made up to 100 mL with ethanol) and, then boiled at 100 C
for 10 min. The mixture was then cooled at room temperature
and centrifuged at 4000g for 10 min. The whole supernatant
and plasma was transferred into a spectrophotometer cuvette
and read at 535 nm. Calibration was performed by using the
acid hydrolysis of 1, 1, 3, 3 tetra-methoxy propane, as a stan-
dard. The MDA present within the sample was calculated by
using the extinction coefﬁcient of 1.56 · 105 M/cm and ex-
pressed as the unit of nM/mg of tissue or nM/mL of plasma.
2.4.4. Electrolytes marker
2.4.4.1. Biochemical estimation of serum Na & K (Sunderman,
1959). Sodium is precipitated as a triple salt with magnesium
& uranyl acetate. The excess of uranyl ions is reacted with
ferrocyanide in an acidic medium to develop a brownish color.
The intensity of the color produced is inversely proportional to
the concentration of sodium in the sample. Potassium reacts
with sodium tetra phenyl boron in a specially prepared buffer
to form a colloidal suspension. The amount of the turbidity
produced is directly proportional to the concentration of
potassium in the sample.
2.5. Statistical analysis
The values were expressed as mean ± S.E. Data were analyzed
using one-way ANOVA followed by t-test. p value < 0.05 was
considered as signiﬁcant.
Table 4 Anti-uremic & anti-oxidative effect of alpha-lipoic
acid at two different doses (50 & 100 mg/kg of body weight) on
plasma urea & creatinine conc. on acetaminophen induced
uremic male albino rats. Data are expressed as mean ± S.E.
(n= 8). ANOVA followed by multiple two-tail t-test and data
with different superscripts (a, b, c, d) in a speciﬁc vertical
column differ from each other signiﬁcantly (p< 0.05).
Groups Urea
(mg/dL of blood plasma)
Creatinine
(mg/dL of blood plasma)
I 11.16 ± 0.93a 1.11 ± 0.22a
II 60.61 ± 3.12b 7.30 ± 1.44b
III 34.17 ± 2.23c 3.30 ± 1.17c
IV 43.69 ± 2.94d 4.95 ± 0.67d
Group I – control, Group II – acetaminophen induced uremia,
Groups III & IV – acetaminophen + co-administration of ALA at
the dose 50 & 100 mg/kg of body wt., respectively.
Table 5 Anti-uremic & anti-oxidative effect of alpha-lipoic
acid at two different doses (50 & 100 mg/kg of body weight) on
plasma sodium & potassium conc. on acetaminophen induced
uremic male albino rats. Data are expressed as mean ± S.E.
(n= 8). ANOVA followed by multiple two-tail t-test and data
with different superscripts (a, b, c, d) in a speciﬁc vertical
column differ from each other signiﬁcantly (p< 0.05).
Groups Sodium (mmol/L) Potassium (mmol/L)
I 123.95 ± 4.68a 5.58 ± 0.59a
II 273.12 ± 6.46b 2.88 ± 0.29b
III 170.9 ± 13.07a 4.09 ± 0.36a
IV 209.16 ± 13.92d 6.32 ± 0.50a
Group I – control, Group II – acetaminophen induced uremia,
Groups III & IV – acetaminophen + co-administration of ALA at
the dose 50 & 100 mg/kg of body wt., respectively.
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3.1. Body weight & somatic indices of kidneys
Body weight increased at the end of experiment in Groups I,
III compared to their initial body weight (Table 1). In Groups
II & IV rats, the percentage in the increase in body growth was
dramatically less than the other groups due to acetaminophen
induced oxidative stress (Table 2).
3.2. Serum urea & creatinine
Serum urea & creatinine levels were signiﬁcantly higher in ure-
mic rats treated with acetaminophen alone than rats in Groups
I, III & IV (p< 0.05, Table 5). ALA in addition to acetamino-
phen treatment group caused decreases in serum urea & creat-
inine levels when compared with control.
3.3. Activities of catalase & SOD
In Groups I, III & IV, CAT activities in blood & kidney were
elevated, compared to Group II. After acetaminophen treat-ment (Group II), the activity of this enzyme in blood & kid-
ney was decreased signiﬁcantly, compared with Group I.
There was a signiﬁcant protection in catalase activity after
co-administration of ALA (Groups III & IV), compared with
the animals only treated with acetaminophen (Group II)
(Table 3). Administration of ALA to acetaminophen treated
animals (Groups III & IV) & Group I resulted in signiﬁcant
elevation in the activity of SOD in blood & kidney, compared
to the animals in Group II (p< 0.05, Table 3). The activity
of this enzyme was decreased signiﬁcantly in blood & kidney,
compared to Group II, in comparison with Group I
(p< 0.05). Acetaminophen treatment followed by the
co-administration of ALA to the animals in Groups III &
IV resulted in a signiﬁcant restoration of the SOD activity,
compared with Group II, & the values were resettled to the
control group.
3.4. Quantiﬁcation of MDA
Quantities of MDA was increased signiﬁcantly in blood & kid-
ney of Group II animals, compared to Groups I, III & IV
(p< 0.05, Table 4). In the acetaminophen treated rats (Group
II), 10 days of acetaminophen injection resulted in a signiﬁcant
elevation in the values of both parameters in blood & kidney.
However, in Groups III & IV co-administration of ALA sig-
niﬁcantly decreased MDA quantities & these values were reset-
tled to the control level.
3.5. Alteration of electrolytes on plasma
In uremia, levels of sodium and potassium are one of the
important parameters for electrolyte imbalance. Due to excess
accumulation of waste products in body, sodium level is signif-
icantly increased in uremic group & potassium level is lower.
After biochemical estimation there is a signiﬁcant (p< 0.05)
high plasma sodium level in uremic group compared to
other groups and a signiﬁcant (p< 0.05) low plasma potas-
sium level in uremic (Group II) group compared to control
(Group I).
4. Discussion
Acetaminophen over dose is often linked to many metabolic
disorders including serum electrolyte, urea & creatinine
derangements. Increased concentration of serum urea & creat-
inine are considered for investigating drug induced nephro-
toxicity in animals & man (Ohkawa et al., 1979). Blood
urea nitrogen is found in the liver protein that is derived from
diet or tissue source & is normally excreted in the urine. In
renal disease, the serum urea accumulates because the rate
of serum urea production exceeds the rate of clearance (May-
ne, 1994). Creatinine on the other hand is mostly derived
from endogenous source by tissue creatinine breakdown. Ele-
vation of urea and creatinine levels in the serum was taken as
the index of nephrotoxicity (Anwar et al., 1999; Bennit et al.,
1982). In this study, acetaminophen induced nephrotoxicity
showed a signiﬁcant (p< 0.05) increase in the plasma urea
and creatinine concentrations in Group II (acetaminophen
induced) rats when compared to Group I (control group).
Moreover, oral administration of ALA signiﬁcantly
(p< 0.05) decreased plasma urea and creatinine in Groups
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shown that oxidation stress is highly present in patients with
renal disease (Vaziri, 2004). It is known that LDL from ure-
mic patients presents an elevated susceptibility to oxidation.
Uremic oxidative stress is characterized from a biochemical
point of view as a state of reactive aldehyde & oxidized thiol
group accumulation, with depletion of reduced thiol group,
which are particularly important as part of anti-oxidant de-
fence. Previous studies have clearly demonstrated that acute
acetaminophen overdose increases the lipid peroxidation
and suppresses the anti-oxidant defence mechanisms in renal
tissues (Abdel-Zaher et al., 2007). Several investigations have
shown that acetaminophen induced nephrotoxicity is associ-
ated with lipid peroxidation. This is ascribed to a free radical
mediated chain reaction that damages cell membranes &
MDA is a good indicator of the degree of lipid peroxidation.
Alpha-lipoic acid is characterized by high reactivity towards
reactive oxygen species & its capability of increasing tissue
levels of anti-oxidant enzymes (Packer et al., 1995; Shay
et al., 2008). It has been demonstrated that lipoic acid reduces
oxidative stress in healthy adults & diabetic patients by
decreasing signiﬁcantly lipid hydroperoxide formation (Pack-
er et al., 1995; Smith et al., 2004). The protective action of al-
pha-lipoic acid against lipid peroxidation as a factor
modifying membrane organization may be due alpha-lipoic
acid’s ability to scavenge the free radicals, which are produced
during the peroxidation of lipids (EI-Sokkary et al., 2003).
However in the acetaminophen treated animals the MDA lev-
els are increased signiﬁcantly, when compared to control rats.
On administration of the ALA, levels of MDA decreased
signiﬁcantly (p< 0.05) when compared to acetaminophen in-
duced rats (Group II). Oxidative stress and lipid peroxidation
are early events related to radicals generated during the hepa-
tic metabolism of acetaminophen. Also the generation of
reactive oxygen species has been proposed as a mechanism
by which many chemicals can induce nephrotoxicity (Somani
et al., 2000). During kidney injury, superoxide radicals are
generated at the site of damage, which modulate SOD and
CAT, resulting in the loss of activity and accumulation of
superoxide radical, which damages kidney. SOD and CAT
are the most important enzymes involved in ameliorating
the effects of oxygen metabolism (Pande and Flora, 2002).
The present study also demonstrated that acute acetamino-
phen overdose resulted in a signiﬁcant decrease in the SOD
and CAT activities in Group II, when compared with control
groups but co-administration of ALA in acetaminophen trea-
ted groups (Groups III & IV) can show a signiﬁcant increase
(p< 0.05) in SOD and CAT activities in blood & kidney &
this anti-oxidant enzymes level is signiﬁcantly higher in high
dose of ALA treated group (Group IV).
5. Conclusion
In conclusion, alpha-lipoic acid had shown a signiﬁcant anti-
uremic activity & anti-oxidative properties on acetaminophen
induced uremia & increases anti-oxidative properties on acet-
aminophen treated uremic rats.
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